Cancer phenotype in 19 families with TP53 mutations

被引：0
|
作者：
Birch, JM
Varley, JM
Kelsey, AM
机构：
[1] ROYAL MANCHESTER CHILDRENS HOSP,MANCHESTER,LANCS,ENGLAND
[2] PATERSON INST CANC RES,MANCHESTER,LANCS,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] TP53 Mutations in Nonsmall Cell Lung Cancer
    Mogi, Akira
    Kuwano, Hiroyuki
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [32] TP53 Gene Mutations in Prostate Cancer Progression
    Ecke, Thorsten H.
    Schlechte, Horst H.
    Schiemenz, Katrin
    Sachs, Markus D.
    Lenk, Severin V.
    Rudolph, Birgit D.
    Loening, Stefan A.
    [J]. ANTICANCER RESEARCH, 2010, 30 (05) : 1579 - 1586
  • [33] The Repertoire of TP53 Mutations in Endometrioid Endometrial Cancer
    Weigelt, B.
    Hussein, Y. R.
    Soslow, R. A.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 311A - 311A
  • [34] Therapeutic targeting of TP53 nonsense mutations in cancer
    Strandgren, Charlotte
    Wiman, Klas G.
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 2024, 129
  • [35] WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer
    Pizurica, Marija
    Larmuseau, Maarten
    Van der Eecken, Kim
    van Brienen, Louise de Schaetzen
    Carrillo-Perez, Francisco
    Isphording, Simon
    Lumen, Nicolaas
    Van Dorpe, Jo
    Ost, Piet
    Verbeke, Sofie
    Gevaert, Olivier
    Marchal, Kathleen
    [J]. CANCER RESEARCH, 2023, 83 (08)
  • [36] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Grill, Sabine
    Ramser, Juliane
    Hellebrand, Heide
    Pfarr, Nicole
    Boxberg, Melanie
    Brambs, Christine
    Ditsch, Nina
    Meindl, Alfons
    Gross, Eva
    Meitinger, Thomas
    Kiechle, Marion
    Quante, Anne S.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (06) : 1557 - 1567
  • [37] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Sabine Grill
    Juliane Ramser
    Heide Hellebrand
    Nicole Pfarr
    Melanie Boxberg
    Christine Brambs
    Nina Ditsch
    Alfons Meindl
    Eva Groß
    Thomas Meitinger
    Marion Kiechle
    Anne S. Quante
    [J]. Archives of Gynecology and Obstetrics, 2021, 303 : 1557 - 1567
  • [38] Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families
    Manoukian, Siranoush
    Peissel, Bernard
    Pensotti, Valeria
    Barile, Monica
    Cortesi, Laura
    Stacchiotti, Silvia
    Terenziani, Monica
    Barbera, Floriana
    Pasquini, Graziella
    Frigerio, Simona
    Pierotti, Marco A.
    Radice, Paolo
    Della-Torre, Gabriella
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 601 - 606
  • [39] Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families
    M Zelada-Hedman
    A-L Børresen-Dale
    A Claro
    J Chen
    L Skoog
    A Lindblom
    [J]. British Journal of Cancer, 1997, 75 : 1201 - 1204
  • [40] Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families
    ZeladaHedman, M
    BorresenDale, AL
    Claro, A
    Chen, J
    Skoog, L
    Lindblom, A
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1201 - 1204
12345